Arkansas Weight Loss Clinic
Arkansas Weight Loss Clinic · 805 Windover Road · Jonesboro, AR 72401
4.4· 17 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
About this practice
The official website for Arkansas Weight Loss Clinic in Jonesboro, AR did not load (SSLError: HTTPSConnectionPool(host='www.arkansaswellnessclinic.com', port=443): Max retries exceeded with url: / (Caused by SSLError(SSLCertVerificationError(1, "[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: Hostname mismatch, certificate is not valid for 'www.arkansaswellnessclinic.com'. (_ssl.c:1029)")))), so this summary cannot be grounded in first-party page content. No medications, prices, or services are inferred from the directory dump.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2024-06-13. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.4 across 17 Google reviews. Of the 17 reviews we analyzed, 14 (82%) are positive (4–5★) and 3 (18%) are negative (1–2★).
What patients like
- Friendly, helpful staff2 reviews
Common complaints
- Staff or front-desk issues3 of 3 negative
Most recent Google reviews
Shanna R.★★★★★2023-05-18I love love this place, I have lost quite a bit of weight and am very happy with this place so far!
Lori M.★★★★★2022-05-16Super unprofessional (and ever changing) staff. Their program is very BAD and extremely unfulfilling. They honestly don't give a rip about you - all they want to do is push their worthless shots on you. Definitely explore your options before you patronize this establishment because your success means absolutely nothing to these people. Honestly.
Carol L.★★★★★2020-05-29I went there thinking I would be consulted with my weight loss but got none. I took the shots and followed the diet for two months and gained weight. There was no one to help me, the male nurse never looked at me when speaking with me about how I could be successful in weight loss, only what I was doing wrong, which seemed to be everything. I wasted my money on this so I went back to Weight Watchers where I then began losing weight immediately. Oh well, lesson learned.
Lisa M.★★★★★2019-08-05I love the staff. Clean atmosphere. In responce to one of the reviews, it is a business and people have to make money. Research the shots they offer and there is science behind how they help you loose weight
Dorsey★★★★★2019-06-11Help me with weight loss.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs